Form 10-Q
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D. C. 20549

 

 

FORM 10-Q

 

 

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For Quarterly Period Ended September 30, 2009

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For Transition Period from              to             .

Commission File Number 1-12658

 

 

ALBEMARLE CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

VIRGINIA   54-1692118

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

451 FLORIDA STREET

BATON ROUGE, LOUISIANA

  70801
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code - (225) 388-8011

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ¨    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

  Large accelerated filer    x       Accelerated filer   ¨
  Non-accelerated filer    ¨    (Do not check if a smaller reporting company)    Smaller reporting company   ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

Number of shares of common stock, $.01 par value, outstanding as of November 1, 2009: 91,680,006

 

 

 


Table of Contents

ALBEMARLE CORPORATION

INDEX – FORM 10-Q

 

          Page
Number(s)
PART I.    FINANCIAL INFORMATION   

Item 1.

  

Financial Statements (Unaudited)

  
  

Consolidated Statements of Income – Three Months and Nine Months Ended September 30, 2009 and 2008

   3
  

Condensed Consolidated Balance Sheets – September 30, 2009 and December 31, 2008

   4
  

Condensed Consolidated Statements of Cash Flows – Nine Months Ended September 30, 2009 and 2008

   5
  

Condensed Consolidated Statements of Comprehensive Income (Loss) – Three Months and Nine Months Ended September 30, 2009 and 2008

   6
  

Notes to the Condensed Consolidated Financial Statements

   7-13

Item 2.

  

Management’s Discussion and Analysis of Financial Condition and Results of Operations

   14-29

Item 3.

  

Quantitative and Qualitative Disclosures about Market Risk

   29-30

Item 4.

  

Controls and Procedures

   30
PART II.    OTHER INFORMATION   

Item 1.

  

Legal Proceedings

   30

Item 1A.

  

Risk Factors

   30

Item 2.

  

Unregistered Sales of Equity Securities and Use of Proceeds

   31

Item 6.

  

Exhibits

   31
SIGNATURES       32
EXHIBITS      

 

2


Table of Contents

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements (Unaudited).

ALBEMARLE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(In Thousands, Except Per Share Amounts)

(Unaudited)

 

     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2009     2008     2009     2008  

Net sales

   $ 515,276      $ 660,463      $ 1,447,166      $ 1,949,390   

Cost of goods sold

     381,197        506,280        1,112,763        1,464,815   
                                

Gross profit

     134,079        154,183        334,403        484,575   

Selling, general and administrative expenses

     56,171        59,899        153,086        191,016   

Research and development expenses

     14,983        17,392        46,081        51,785   

Port de Bouc charges

     —          —          12,393        —     

Restructuring charges

     —          —          —          3,278   
                                

Operating profit

     62,925        76,892        122,843        238,496   

Interest and financing expenses

     (6,199     (9,815     (18,561     (28,472

Other income (expenses), net

     343        (2,718     488        2,066   
                                

Income before income taxes and equity in net income of unconsolidated investments

     57,069        64,359        104,770        212,090   

Income tax (expense) benefit

     (5,549     (9,878     1,675        (39,406
                                

Income before equity in net income of unconsolidated investments

     51,520        54,481        106,445        172,684   

Equity in net income of unconsolidated investments (net of tax)

     5,809        6,281        17,962        21,975   
                                

Net income

     57,329        60,762        124,407        194,659   

Net income attributable to noncontrolling interests

     (5,198     (4,587     (8,384     (13,568
                                

Net income attributable to Albemarle Corporation

   $ 52,131      $ 56,175      $ 116,023      $ 181,091   
                                

Basic earnings per share

   $ 0.57      $ 0.61      $ 1.27      $ 1.97   
                                

Diluted earnings per share

   $ 0.57      $ 0.61      $ 1.26      $ 1.95   
                                

Cash dividends declared per share of common stock

   $ 0.125      $ 0.12      $ 0.375      $ 0.36   

Weighted-average common shares outstanding - basic

     91,588        91,395        91,481        91,846   

Weighted-average common shares outstanding - diluted

     92,174        92,463        91,955        92,977   

See accompanying Notes to the Condensed Consolidated Financial Statements.

 

3


Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In Thousands)

(Unaudited)

 

     September 30,
2009
    December 31,
2008
 

ASSETS

    

Current assets:

    

Cash and cash equivalents

   $ 260,434      $ 253,303   

Trade accounts receivable, less allowance for doubtful accounts (2009 - $2,010; 2008 - $1,899)

     293,548        280,601   

Other accounts receivable

     32,226        47,157   

Inventories

     364,169        538,857   

Other current assets

     52,376        59,005   
                

Total current assets

     1,002,753        1,178,923   
                

Property, plant and equipment, at cost

     2,416,735        2,322,996   

Less accumulated depreciation and amortization

     1,374,405        1,310,648   
                

Net property, plant and equipment

     1,042,330        1,012,348   

Investments

     145,090        121,951   

Other assets

     138,504        113,717   

Goodwill

     297,490        278,767   

Other intangibles, net of amortization

     153,981        167,011   
                

Total assets

   $ 2,780,148      $ 2,872,717   
                

LIABILITIES AND EQUITY

    

Current liabilities:

    

Accounts payable

   $ 160,577      $ 224,333   

Accrued expenses

     135,797        170,512   

Current portion of long-term debt

     27,721        26,202   

Dividends payable

     10,693        9,675   

Income taxes payable

     7,084        7,645   
                

Total current liabilities

     341,872        438,367   
                

Long-term debt

     793,098        906,062   

Postretirement benefits

     47,985        47,803   

Pension benefits

     148,349        146,381   

Other noncurrent liabilities

     123,994        142,783   

Deferred income taxes

     80,578        74,838   

Commitments and contingencies

    

Equity:

    

Albemarle Corporation shareholders’ equity:

    

Common stock, $.01 par value, issued and outstanding – 91,683 in 2009 and 90,980 in 2008

     917        910   

Additional Paid-In Capital

     14,294        —     

Accumulated other comprehensive loss

     (55,225     (100,642

Retained earnings

     1,237,077        1,165,503   
                

Total Albemarle Corporation shareholders’ equity

     1,197,063        1,065,771   
                

Noncontrolling interests

     47,209        50,712   
                

Total equity

     1,244,272        1,116,483   
                

Total liabilities and equity

   $ 2,780,148      $ 2,872,717   
                

See accompanying Notes to the Condensed Consolidated Financial Statements.

 

4


Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In Thousands)

(Unaudited)

 

     Nine Months Ended
September 30,
 
     2009     2008  

Cash and cash equivalents at beginning of year

   $ 253,303      $ 130,551   
                

Cash flows from operating activities:

    

Net income

     124,407        194,659   

Adjustments to reconcile net income to cash flows from operating activities:

    

Depreciation and amortization

     74,539        81,555   

Port de Bouc charges

     12,393        —     

Restructuring charges

     —          3,278   

Stock-based compensation

     (1,878     13,785   

Excess tax benefits realized from stock-based compensation arrangements

     (2,038     (7,688

Equity in net income of unconsolidated investments

     (17,962     (21,975

Working capital changes

     77,279        (116,036

Dividends received from unconsolidated investments and nonmarketable securities

     13,060        8,737   

Pension and postretirement expense

     7,229        1,922   

Pension and postretirement contributions

     (10,616     (9,005

Unrealized (gain) loss on investments in marketable securities

     (2,652     1,021   

Net change in noncurrent income tax payables and receivables

     (16,369     6,266   

Net change in noncurrent environmental liabilities

     (3,224     (2,658

Deferred income taxes

     (10,385     9,938   

Other, net

     15,625        (2,046
                

Net cash provided from operating activities

     259,408        161,753   
                

Cash flows from investing activities:

    

Capital expenditures

     (83,610     (63,467

Cash payments related to the Thann facility divestiture

     —          (2,556

Cash payments related to the Port de Bouc facility divestiture

     (16,440     —     

Cash payments related to acquisitions

     (2,078     (57,283

Collection of note receivable from sale of land

     —          6,000   

Investments in marketable securities

     (228     (2,915

Investments in other corporate investments

     (40     (49
                

Net cash used in investing activities

     (102,396     (120,270
                

Cash flows from financing activities:

    

Repayments of long-term debt

     (133,332     (42,605

Proceeds from borrowings

     20,269        285,303   

Dividends paid to shareholders

     (33,306     (31,394

Purchases of common stock

     —          (163,502

Proceeds from exercise of stock options

     4,083        3,931   

Excess tax benefits realized from stock-based compensation arrangements

     2,038        7,688   

Withholding taxes paid on stock-based compensation award distributions

     (4,837     (11,106

Dividends paid to noncontrolling interests

     (8,911     (11,836

Other

     —          (107
                

Net cash (used in) provided from financing activities

     (153,996     36,372   
                

Net effect of foreign exchange on cash and cash equivalents

     4,115        (1,195
                

Increase in cash and cash equivalents

     7,131        76,660   
                

Cash and cash equivalents at end of period

   $ 260,434      $ 207,211   
                

See accompanying Notes to the Condensed Consolidated Financial Statements.

 

5


Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(In Thousands)

(Unaudited)

 

     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2009     2008     2009     2008  

Net income

   $ 57,329      $ 60,762      $ 124,407      $ 194,659   

Other comprehensive income (loss), net of tax:

        

Unrealized gain (loss) on marketable securities

     1        (2     2        (2

Amortization of realized loss on treasury lock agreements

     28        35        100        105   

Changes in net loss (gain) and prior service cost

     692        (399     (5,538     (1,097

Foreign currency translation

     33,745        (91,212     50,853        (22,536
                                

Total other comprehensive income (loss), net of tax

     34,466        (91,578     45,417        (23,530
                                

Comprehensive income (loss)

     91,795        (30,816     169,824        171,129   
                                

Comprehensive loss attributable to noncontrolling interests

     (5,198     (4,587     (8,384     (13,568
                                

Comprehensive income (loss) attributable to Albemarle Corporation

   $ 86,597      $ (35,403   $ 161,440      $ 157,561   
                                

See accompanying Notes to the Condensed Consolidated Financial Statements.

 

6


Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

1. In the opinion of management, the accompanying condensed consolidated financial statements of Albemarle Corporation and our wholly owned, majority owned and controlled subsidiaries (collectively, “Albemarle,” “we,” “us,” “our,” or “the Company”) contain all adjustments necessary for a fair presentation, in all material respects, of our condensed consolidated financial position as of September 30, 2009 and December 31, 2008, and our condensed consolidated results of operations and comprehensive income for the three-month and nine-month periods ended September 30, 2009 and 2008, and our condensed consolidated cash flows for the nine-month periods ended September 30, 2009 and 2008. All adjustments are of a normal and recurring nature. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2008, which was filed with the Securities and Exchange Commission, or the SEC, on February 27, 2009. The December 31, 2008 consolidated balance sheet data herein was derived from audited financial statements, but does not include all disclosures required by generally accepted accounting principles, or GAAP, in the United States, or the U.S. The results of operations for the three-month and nine-month periods ended September 30, 2009 are not necessarily indicative of the results to be expected for the full year. Certain reclassifications have been made to the accompanying consolidated financial statements and the notes thereto to conform to the current presentation. We have evaluated subsequent events through November 6, 2009, which is the date we issued the financial statements.

2. On January 1, 2009, we adopted new accounting guidance that changed the accounting for and reporting of minority interests (now referred to as noncontrolling interests). Noncontrolling interests are now classified as equity in our consolidated financial statements. Our consolidated statement of income presentation format was also changed and net income now includes the net income for both the parent and the noncontrolling interests, with disclosure of both amounts on the consolidated statement of income. The calculation of earnings per share continues to be based on net income amounts attributable to the parent. Prior period amounts related to noncontrolling interests have been reclassified to conform to the current period presentation.

3. The nine-month period ended September 30, 2009 includes charges amounting to $12.4 million ($8.2 million after income taxes, or $0.09 per share) that relate to the costs of a final contract settlement arising from our 2008 divestiture of the Port de Bouc, France facility. Future cash payments associated with the settlement should be complete by the end of 2009.

The nine-month period ended September 30, 2008 includes charges amounting to $3.3 million ($2.1 million after income taxes, or $0.02 per share) that relate to severance costs in conjunction with personnel reductions at our former Richmond, Virginia headquarters and our Singapore sales office.

4. Our consolidated statements of income include the following foreign exchange transaction gains (losses) for the three-month and nine-month periods ended September 30, 2009 and 2008:

 

     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2009     2008     2009     2008  
     (In thousands)  

Cost of goods sold

   $ 760      $ (463   $ (1,307   $ 1,712   

Other income, net

     (613     (3,581     (1,333     (1,823
                                

Total foreign exchange transaction gains (losses)

   $ 147      $ (4,044   $ (2,640   $ (111
                                

 

7


Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements—(Continued)

 

5. Our effective tax rate fluctuates based on, among other factors, where income is earned and the level of income relative to available tax credits. The significant differences between the U.S. federal statutory income tax rate on pretax income and the effective income tax rate for the three-month and nine-month periods ended September 30, 2009 and 2008, respectively, are as follows:

 

     % of Income Before Income Taxes  
     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2009     2008     2009     2008  

Federal statutory rate

   35.0   35.0   35.0   35.0

State taxes, net of federal tax benefit

   0.3      0.4      0.3      0.4   

Impact of foreign operations, net

   (24.7   (18.4   (24.0   (15.5

Increase in valuation allowance

   0.5      1.8      1.6      0.6   

Depletion

   (0.9   (1.7   (1.3   (1.5

Effect of net income attributable to noncontrolling interests

   (0.9   (0.7   (0.8   (0.6

Revaluation of unrecognized tax benefits/reserve requirements

   0.4      1.5      (11.5   1.2   

Other items, net

   —        (2.6   (0.9   (1.0
                        

Effective income tax rate

   9.7   15.3   (1.6 )%    18.6
                        

The nine-month period ended September 30, 2009 includes various non-recurring items totaling a $15.7 million net benefit, consisting mainly of $9.2 million in one time net benefits due primarily to decreases in unrecognized tax benefit liabilities and deferred tax assets related to an issue settled in the current U.S. Internal Revenue Service, or IRS, examination of years 2005 through 2007, a $4.2 million net benefit related to the charges from our Port de Bouc, France facility divestiture, $3.7 million of one time benefits due mainly to unrecognized tax benefits, partially offset by a $1.2 million increase in a valuation allowance for losses at our Brazilian subsidiary.

Our unrecognized tax benefit liabilities (which are included in “Other noncurrent liabilities”) amounted to $56.6 million and $77.5 million at September 30, 2009 and December 31, 2008, respectively. The decrease of $20.9 million resulted from a $12.6 million reduction related to an issue settled in the current U.S. IRS examination of 2005 through 2007 as well as a $8.3 million reduction mainly for prior year tax positions on transfer pricing (which resulted in reducing the related assets for corresponding benefits included in “Other assets” from $39.9 million at December 31, 2008 to $33.5 million at September 30, 2009).

We are subject to income taxes in the U.S. and numerous foreign jurisdictions. We are no longer subject to U.S. federal income tax examinations by tax authorities for years preceding 2005. The IRS has completed a review of our income tax returns through year 2004. During 2008, we received examination notifications from the IRS on tax years 2005 through 2007. We anticipate tax resolutions related to these years in either 2009 or 2010.

With respect to jurisdictions outside the U.S., we are no longer subject to income tax audits for years preceding 2002.

While we believe we have adequately provided for all tax positions, amounts asserted by taxing authorities could be greater than our accrued position. Accordingly, additional provisions on federal and foreign tax-related matters could be recorded in the future as revised estimates are made or the underlying matters are settled or otherwise resolved.

Since the timing of resolutions and/or closure of tax audits is uncertain, it is difficult to predict with certainty the range of reasonably possible significant increases or decreases in the liability for unrecognized tax benefits that may occur within the next twelve months. Our current view is that it is reasonably possible that we could record a decrease in the liability for unrecognized tax benefits, relating to a number of issues, up to approximately $16 million as a result of settlements with taxing authorities and closure of tax statutes.

6. On January 1, 2009, we adopted new accounting guidance associated with share-based payment transactions considered to be participating securities. This guidance states that unvested share-based payment awards that contain nonforfeitable rights to dividends, such as certain of our restricted stock awards, are participating securities and therefore shall be included in the earnings per share calculation pursuant to the two class method. In addition, the guidance requires all prior-period earnings per share data to be adjusted retrospectively, and as a result, all prior period earnings per share data presented herein have been adjusted to conform to these provisions. Basic earnings per share decreased $0.01 for the three-month period ended September 30, 2008 as a result of an increase in our basic weighted-average common shares outstanding of approximately 321,000 shares. Diluted weighted-average common shares outstanding increased by approximately 198,000

 

8


Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements—(Continued)

 

shares for the three-month period ended September 30, 2008. Basic earnings per share decreased $0.01 for the nine-month period ended September 30, 2008 as a result of an increase in our basic weighted-average common shares outstanding of approximately 311,000 shares. Diluted weighted-average common shares outstanding increased by approximately 203,000 shares for the nine-month period ended September 30, 2008. There was no impact on our reported basic or diluted earnings per share for the three-month and nine-month periods ended September 30, 2009. Our basic and diluted weighted-average common shares outstanding increased by approximately 311,000 and 132,000 shares, respectively, for the three-month period ended September 30, 2009. For the nine-month period ended September 30, 2009, our basic and diluted weighted-average common shares outstanding increased by approximately 327,000 and 167,000 shares, respectively.

Basic and diluted earnings per share for the three-month and nine-month periods ended September 30, 2009 and 2008 are calculated as follows:

 

     Three Months Ended
September 30,
   Nine Months Ended
September 30,
     2009    2008    2009    2008
     (In thousands, except per share amounts)

Basic earnings per share

           

Numerator:

           

Net income attributable to Albemarle Corporation

   $ 52,131    $ 56,175    $ 116,023    $ 181,091
                           

Denominator:

           

Weighted-average common shares for basic earnings per share

     91,588      91,395      91,481      91,846
                           

Basic earnings per share

   $ 0.57    $ 0.61    $ 1.27    $ 1.97
                           

Diluted earnings per share

           

Numerator:

           

Net income attributable to Albemarle Corporation

   $ 52,131    $ 56,175    $ 116,023    $ 181,091
                           

Denominator:

           

Weighted-average common shares for basic earnings per share

     91,588      91,395      91,481      91,846

Incremental shares under stock compensation plans

     586      1,068      474      1,131
                           

Total shares

     92,174      92,463      91,955      92,977
                           

Diluted earnings per share

   $ 0.57    $ 0.61    $ 1.26    $ 1.95
                           

7. Cash dividends declared for the three-month period ended September 30, 2009 totaled 12.5 cents per share, and included a dividend of 12.5 cents declared on July 28, 2009 and paid on October 1, 2009. Cash dividends declared for the nine-month period ended September 30, 2009 totaled 37.5 cents per share. Cash dividends declared for the three-month period ended September 30, 2008 totaled 12.0 cents per share, and included a dividend of 12.0 cents declared on July 30, 2008 and paid October 1, 2008. Cash dividends declared for the nine-month period ended September 30, 2008 totaled 36.0 cents per share.

8. The following table provides a breakdown of inventories at September 30, 2009 and December 31, 2008:

 

     September 30,
2009
   December 31,
2008
     (In thousands)

Finished goods

   $ 254,828    $ 395,919

Raw materials

     62,776      95,617

Stores, supplies and other

     46,565      47,321
             

Total inventories

   $ 364,169    $ 538,857
             

 

9


Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements—(Continued)

 

9. Long-term debt at September 30, 2009 and December 31, 2008 consists of the following:

 

     September 30,
2009
   December 31,
2008
     (In thousands)

Variable-rate domestic bank loans

   $ 405,950    $ 522,835

Senior notes

     324,821      324,796

Fixed rate foreign borrowings

     42,063      47,640

Variable-rate foreign bank loans

     35,747      23,320

Capital lease obligation

     11,607      12,975

Miscellaneous

     631      698
             

Total

     820,819      932,264

Less amounts due within one year

     27,721      26,202
             

Total long-term debt

   $ 793,098    $ 906,062
             

Maturities of long-term debt are as follows: 2009—$18.0 million; 2010—$12.1 million; 2011—$9.0 million; 2012—$9.5 million; 2013—$433.2 million and 2014 through 2017—$339.0 million.

10. We have the following recorded environmental liabilities primarily included in “Other noncurrent liabilities” at September 30, 2009 (in thousands):

 

Beginning balance at December 31, 2008

   $ 18,970   

Changes in estimates

     (2,252

Payments

     (1,258

Foreign exchange

     453   
        

Ending balance at September 30, 2009

   $ 15,913   
        

The amounts recorded represent our future remediation and other anticipated environmental liabilities. Although it is difficult to quantify the potential financial impact of compliance with environmental protection laws, management estimates (based on the latest available information) that there is a reasonable possibility that future environmental remediation costs associated with our past operations, in excess of amounts already recorded, could be up to approximately $18 million before income taxes.

We believe that any sum we may be required to pay in connection with environmental remediation matters in excess of the amounts recorded should occur over a period of time and should not have a material adverse effect upon our results of operations, financial condition or cash flows on a consolidated annual basis, although any such sum could have a material adverse impact on our results of operations, financial condition or cash flows in a particular quarterly reporting period.

On July 3, 2006, we received a Notice of Violation, or NOV, from the U.S. Environmental Protection Agency Region 4, or EPA, regarding the implementation of the Pharmaceutical Maximum Achievable Control Technology standards at our plant in Orangeburg, SC. The alleged violations include (i) the applicability of the specific regulations to certain intermediates manufactured at the plant, (ii) failure to comply with certain reporting requirements, (iii) improper evaluation and testing to properly implement the regulations and (iv) the sufficiency of the leak detection and repair program at the plant. We are currently engaged in discussions with the EPA seeking to resolve these allegations, but no assurances can be given that we will be able to reach a resolution that is acceptable to both parties. Any settlement or finding adverse to us could result in the payment by us of fines, penalties, capital expenditures, or some combination thereof. At this time, it is not possible to predict with any certainty the outcome of our discussions with the EPA or the financial impact which may result therefrom. However, we do not expect any financial impact to have a material adverse effect on our results of operations or financial position.

11. Segment income represents operating profit (adjusted for significant non-recurring items) and equity in net income of unconsolidated investments and is reduced by net income attributable to noncontrolling interests. Segment data includes intersegment transfers of raw materials at cost, foreign exchange transaction gains and losses and allocations for certain corporate costs.

 

10


Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements—(Continued)

 

Summarized financial information concerning our reportable segments is shown in the following table. Corporate & other includes corporate-related items not allocated to the reportable segments.

 

     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2009     2008     2009     2008  
     (In thousands)  

Net sales:

        

Polymer Additives

   $ 196,716      $ 261,746      $ 492,636      $ 766,844   

Catalysts

     188,911        231,562        600,101        716,045   

Fine Chemicals

     129,649        167,155        354,429        466,501   
                                

Total net sales

   $ 515,276      $ 660,463      $ 1,447,166      $ 1,949,390   
                                

Segment operating profit:

        

Polymer Additives

   $ 27,243      $ 28,705      $ 31,562      $ 86,337   

Catalysts

     28,845        30,941        90,314        112,617   

Fine Chemicals

     16,482        26,830        32,525        77,983   
                                

Subtotal

   $ 72,570      $ 86,476      $ 154,401      $ 276,937   
                                

Equity in net income (loss) of unconsolidated investments:

        

Polymer Additives

   $ 1,293      $ 777      $ 1,563      $ 3,454   

Catalysts

     4,543        5,544        16,480        18,598   

Fine Chemicals

     —          —          —          —     

Corporate & other

     (27     (40     (81     (77
                                

Total equity in net income of unconsolidated investments

   $ 5,809      $ 6,281      $ 17,962      $ 21,975   
                                

Net (income) loss attributable to noncontrolling interests:

        

Polymer Additives

   $ (2,490   $ (2,078   $ (4,145   $ (6,183

Catalysts

     —          —          —          —     

Fine Chemicals

     (2,244     (2,146     (4,402     (7,304

Corporate & other

     (464     (363     163        (81
                                

Total net income attributable to noncontrolling interests

   $ (5,198   $ (4,587   $ (8,384   $ (13,568
                                

Segment income:

        

Polymer Additives

   $ 26,046      $ 27,404      $ 28,980      $ 83,608   

Catalysts

     33,388        36,485        106,794        131,215   

Fine Chemicals

     14,238        24,684        28,123        70,679   
                                

Total segment income

     73,672        88,573        163,897        285,502   

Corporate & other(1)

     (10,136     (9,987     (19,083     (35,321

Port de Bouc charges

     —          —          (12,393     —     

Restructuring charges

     —          —          —          (3,278

Interest and financing expenses

     (6,199     (9,815     (18,561     (28,472

Other income (expenses), net

     343        (2,718     488        2,066   

Income tax (expense) benefit

     (5,549     (9,878     1,675        (39,406
                                

Net income attributable to Albemarle Corporation

   $ 52,131      $ 56,175      $ 116,023      $ 181,091   
                                

 

(1)

Corporate and other charges for the nine-month period ended September 30, 2009 includes $7.8 million in adjustments associated with the reversal of certain long-term employee benefit accruals. This adjustment is primarily included in “Selling, general and administrative expenses” in our consolidated statements of income.

12. We have contracts with certain of our customers, which serve as guarantees on product delivery and performance according to customer specifications that can cover both shipments on an individual basis as well as blanket coverage of multiple shipments under customer supply contracts, that are executed through certain financial institutions. The financial coverage provided by these guarantees is typically based on a percentage of net sales value.

 

11


Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements—(Continued)

 

In connection with the remediation of a local landfill site as required by the German environmental authorities, we have pledged certain of our land and housing facilities at our Bergheim, Germany plant site with a recorded value of $6.5 million.

In addition, we are involved from time to time in legal proceedings of types regarded as common in our businesses, particularly administrative or judicial proceedings seeking remediation under environmental laws, such as Superfund, products liability and premises liability litigation. We maintain a financial accrual for these proceedings that includes defense costs and potential damages, as estimated by our legal counsel. We also maintain insurance to mitigate certain of these risks. See Note 10 above.

13. The following information is provided for domestic and foreign pension and postretirement benefit plans:

 

     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2009     2008     2009     2008  
     (In thousands)  

Net Periodic Pension Benefit Cost (Credit):

        

Service cost

   $ 2,764      $ 2,937      $ 7,911      $ 9,239   

Interest cost

     8,376        7,944        24,694        23,819   

Expected return of assets

     (10,586     (10,515     (31,752     (31,507

Plan curtailment

     —          (1     —          (173

Amortization of net transition asset

     (2     (2     (7     (7

Amortization of prior service benefit

     (245     (251     (738     (757

Amortization of net loss

     2,939        1,941        9,251        5,855   
                                

Total net periodic pension benefit cost

   $ 3,246      $ 2,053      $ 9,359      $ 6,469   
                                

We have made $2.4 million and $8.1 million in contributions to our qualified and nonqualified pension plans during the three-month and nine-month periods ended September 30, 2009, respectively.

 

     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2009     2008     2009     2008  
     (In thousands)  

Net Periodic Postretirement Benefit Cost (Credit):

        

Service cost

   $ 110      $ 111      $ 329      $ 334   

Interest cost

     942        828        2,826        2,483   

Expected return of assets

     (143     (143     (429     (429

Amortization of prior service benefit

     (1,893     (2,400     (5,678     (7,199

Amortization of net loss

     274        88        822        264   
                                

Total net periodic postretirement benefit credit

   $ (710   $ (1,516   $ (2,130   $ (4,547
                                

We paid approximately $0.8 million and $2.5 million in premiums to the U.S. postretirement benefit plan during the three-month and nine-month periods ended September 30, 2009, respectively.

14. We have the following recorded workforce reduction liabilities included in “Accrued expenses” at September 30, 2009 (in thousands):

 

Beginning balance at December 31, 2008

   $ 20,276   

Payments

     (19,214

Foreign exchange and other

     (267
        

Ending balance at September 30, 2009

   $ 795   
        

During the three-month and nine-month periods ended September 30, 2009, we made payments of $2.6 million and $19.2 million, respectively, as a result of restructuring charges recorded during the year ended December 31, 2008. The majority of the payments under this restructuring plan are expected to be completed by the end of 2009.

 

12


Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements—(Continued)

 

15. In assessing the fair value of financial instruments, we use methods and assumptions that are based on market conditions and other risk factors existing at the time of assessment. Fair value information for our financial instruments is as follows:

Cash and Cash Equivalents, Accounts and Other Receivables and Accounts Payable—The carrying value approximates fair value due to their short-term nature.

Long-Term Debt—The carrying value of long-term debt reported in the accompanying consolidated balance sheets, with the exceptions of the senior notes which we sold on January 20, 2005 and foreign currency denominated debt at Jordan Bromine Company, approximates fair value as substantially all of the long-term debt bears interest based on prevailing variable market rates currently available in the countries in which we have borrowings.

 

     September 30, 2009    December 31, 2008
     Recorded
Amount
   Fair value    Recorded
Amount
   Fair Value
     (In thousands)

Current portion of long-term debt

   $ 27,721    $ 27,645    $ 26,202    $ 26,377

Long-term debt

   $ 793,098    $ 776,126    $ 906,062    $ 856,520

Foreign Currency Exchange Contracts—The fair values of our forward currency exchange contracts are estimated based on current settlement values. At September 30, 2009 and December 31, 2008, the fair value of the forward contracts represented minimal net liability positions on our consolidated balance sheets.

16. In December 2008, the FASB issued accounting guidance which requires additional disclosures regarding benefit plan assets including (a) the investment allocation decision process, (b) the fair value of each major category of plan assets and (c) the inputs and valuation techniques used to measure the fair value of plan assets. The guidance is effective for fiscal years ending after December 15, 2009. We are currently evaluating the additional disclosures required upon adoption of this guidance.

In June 2009, the FASB issued accounting guidance that amends the consolidation guidance applicable to variable interest entities. The guidance is effective as of the beginning of the first fiscal year that begins after November 15, 2009, rendering it effective for us beginning in 2010. We have not yet determined the impact of the provisions of this guidance on our consolidated financial statements.

In June 2009, the FASB issued accounting guidance which established the FASB Accounting Standards CodificationTM, or Codification, which supersedes all existing accounting standard documents and will become the single source of authoritative GAAP (other than guidance issued by the SEC) for all non-governmental entities. The Codification was implemented on July 1, 2009 and is effective for interim and annual periods ending after September 15, 2009. The Codification is not intended to change or alter existing GAAP and did not result in a change in our accounting practice. We have conformed our consolidated financial statements and related notes thereto to the new Codification for the quarter ended September 30, 2009.

 

13


Table of Contents
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following is a discussion and analysis of our financial condition and results of operations since December 31, 2008. A discussion of consolidated financial condition and sources of additional capital is included under a separate heading “Financial Condition and Liquidity” on page 26.

Forward-looking Statements

Some of the information presented in this Quarterly Report on Form 10-Q, including the documents incorporated by reference, may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on our current expectations, which are in turn based on assumptions that we believe are reasonable based on our current knowledge of our business and operations. We have used words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “should,” “will” and variations of such words and similar expressions to identify such forward-looking statements.

These forward-looking statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions, which are difficult to predict and many of which are beyond our control. There can be no assurance, therefore, that our actual results will not differ materially from the results and expectations expressed or implied in the forward-looking statements. Factors that could cause actual results to differ materially include, without limitation:

 

   

deterioration in economic and business conditions;

 

   

future financial and operating performance of our major customers and industries served by us;

 

   

the timing of orders received from customers;

 

   

the gain or loss of significant customers;

 

   

competition from other manufacturers;

 

   

changes in the demand for our products;

 

   

limitations or prohibitions on the manufacture and sale of our products;

 

   

availability of raw materials;

 

   

changes in the cost of raw materials and energy, and our inability to pass through such increases;

 

   

performance of acquired companies;

 

   

changes in our markets in general;

 

   

fluctuations in foreign currencies;

 

   

changes in laws and increased government regulation of our operations or our products;

 

   

the occurrence of claims or litigation;

 

   

the occurrence of natural disasters;

 

   

the inability to maintain current levels of product or premises liability insurance or the denial of such coverage;

 

   

political unrest affecting the global economy, including adverse effects from terrorism or hostilities;

 

   

changes in accounting standards;

 

   

the inability to achieve results from our global cost reduction initiatives as well as our ongoing continuous improvement and rationalization programs;

 

   

changes in interest rates, to the extent such rates (1) affect our ability to raise capital or increase our cost of funds, (2) have an impact on the overall performance of our pension fund investments and (3) increase our pension expense and funding obligations;

 

   

volatility and substantial uncertainties in the debt and equity markets; and

 

   

the other factors detailed from time to time in the reports we file with the SEC.

We assume no obligation to provide revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws. The following discussion should be read together with our consolidated financial statements and related notes included in this Quarterly Report on Form 10-Q.

 

14


Table of Contents

Overview

We are a leading global developer, manufacturer and marketer of highly-engineered specialty chemicals. Our products and services enhance the value of our customers’ end-products by improving performance, providing essential product attributes, lowering cost and simplifying processing. We sell a highly diversified mix of products to a wide range of customers, including petroleum refiners, utilities providers, and manufacturers of consumer electronics, building and construction materials, automotive parts, packaging, pharmachemicals and agrichemicals. We believe that our commercial and geographic diversity, technical expertise, flexible, low-cost global manufacturing base, and experienced management team enable us to maintain leading market positions in those areas of the specialty chemicals industry in which we operate.

Third Quarter 2009

During the third quarter of 2009:

 

   

quarterly net sales of $515.3 million and earnings (net income attributable to Albemarle Corporation) of $52.1 million, or $0.57 per share

 

   

sequential improvement from second quarter 2009 in net sales in all business segments

 

   

sequential segment income improvements from second quarter 2009 in Polymer Additives and Fine Chemicals segments

 

   

continued progress on cost reduction initiatives

Outlook

We are seeing signs of a slow and steady end-market recovery, with positive order trends in several market segments. We believe our initiatives to improve productivity and to reduce operating costs along with a slowly improving business climate should result in continued performance improvement in the second half of 2009. We believe we will have a stronger balance sheet at year-end versus the beginning of this year.

Polymer Additives: While demand continues to improve, we expect a return to historical levels could take an extended period of time. The consumer electronics market is starting to recover, driving demand for our brominated flame retardants. Although we expect continued softness in automotive and construction sectors to continue to impact volumes and profitability of our Polymer Additives segment, we are starting to see some signs of improvement in the automotive sector. As demand returns, we are increasing production rates to meet requirements. We believe improved cost absorption along with the steps we are taking to restructure our operations and reduce cost, should drive solid profitability in the fourth quarter. In the longer term, the increasing standard of living around the globe should drive higher demand for electrical and electronic equipment and new construction, and the potential for increasingly stringent fire-safety regulations and global climate initiatives should increase the need for insulation materials.

Demand has started to pick up in our antioxidants and curatives business in the second half and is expected to stay strong through the remainder of the year. We are continuing to increase our presence in China as we build a foundation for expanding our business in Asia. Expansion of our now wholly owned antioxidants facility in Shanghai is expected to come on-line in 2010.

New product development momentum continues in our Polymer Additives segment. We plan to begin commercializing sales of a new polymeric fire safety product portfolio that will set new standards in the fire safety industry into the next generation of high-performance, fire-safe and sustainable resin systems. We also plan to commercialize a new polyurea curative, which offers greater cure speed flexibility and therefore we believe will expand and increase performance and use.

Catalysts: We expect revenue growth in our Catalysts segment to be driven by global demand in the petroleum and polyolefins markets. While we continue to monitor developments in the global economy, we expect our Catalysts segment profit growth in 2009 to come primarily from new product introductions, value-added products and services that drive efficiencies for refiners, and continued growth in our polyolefin catalysts business.

While refineries continue to combat margin pressures, global demand for oil and consumer fuels and tightening fuel quality regulations will continue to drive demand for our refinery catalysts. As a result of Albemarle’s investment in catalysts research and development, our new product offerings in refinery catalysts will provide technological and economic advantages to address the complex challenges in the refining market. We must also continue to successfully pass through metals costs and work toward optimal inventory levels.

 

15


Table of Contents

Our success in delivering high-value FCC catalysts to the market is helping improve refining yields. New product development in FCC is expected to support improved margins in our FCC business. However, we believe there remains room for further margin improvement, and that in order to be successful we must continue to deliver high-performing, superior quality products to meet the growing demands of refiners for greater value-added products. We continue to face raw material cost pressures related to imported rare earths, aluminum trihydrate and transportation costs.

The polyolefin industry’s demands for catalysts are strong and growing. Our innovative technology advances and superior product stewardship we believe have positioned us to be the leading global polyolefin catalyst provider. We expect continued growth in this sector to be driven by the market’s needs for reliable, value-added catalysts. We expect longer-term growth to be predominantly in the Middle East and Asia regions.

In October 2009, we reached an agreement to form a 50/50 joint venture with Ibn Hayyan Plastic Products Company (TAYF), an affiliate of Saudi Basic Industries Corporation (SABIC). Under the terms of the joint venture agreement, the two parent companies will build a world-scale tri-ethyl aluminum production facility strategically located in the Arabian Gulf Industrial City of Al-Jubail. The joint venture, Saudi Organometallic Chemicals Company (SOCC), is expected to start production by early 2012. This manufacturing joint venture will be established and uniquely positioned to ensure the effective delivery of tri-ethyl aluminum to the region’s growing customer base.

Our marketing and research groups are tightly aligned so we can continue to bring innovative technologies to the market. We will continue to explore new opportunities for our catalysts in the alternative fuels business, which includes biodiesel, Canadian oil sands, gas to liquids (GTL), and coal to liquids (CTL) markets. These opportunities become increasingly viable with oil prices in the $60 – $70 per barrel range.

Fine Chemicals: We believe improving demand in our bromine chain and new product sales in fine chemistry services will generate growth in Fine Chemicals.

Bromine production increased in the third quarter and we expect to sustain those utilization rates to meet fourth quarter demand requirements in performance chemicals as well as in our brominated flame retardants business. Oil completion fluids continue to be impacted by weakness in drilling activity, primarily in the Gulf of Mexico. Rig counts are still at low levels, however the decline seems to be slowing, and we are seeing modest demand recovery in this business. We expect lower unabsorbed cost from increased production in Fine Chemicals to have a positive impact on Fine Chemicals profitability in the fourth quarter.

Our fine chemistry services pipeline continues to be robust with projects for leading chemical, agricultural and pharmaceutical companies. We continue to benefit from a rapid pace of innovation and the introduction of new products, coupled with the movement by pharmaceutical companies to outsource certain research, product development and manufacturing functions. Our successful participation in the development of break-through pharmaceuticals with some large pharmaceutical makers position this business for further opportunities and potentially strong growth.

Our long-term strategic areas of focus in our Fine Chemicals segment are to maximize our bromine franchise value in the performance chemicals sector and to continue the growth of our fine chemistry services business. We are focused on profitably growing our globally competitive bromine and derivatives production network to serve all major bromine consuming products and markets. As we supply bromine feed stocks to our Polymer Additives segment, our profitability is generally impacted as market conditions can change in that sector. We remain confident in continuing to generate growth in profitable niche products leveraged from this service business.

Corporate and Other: We are continuing our focus on lowering cost, reducing working capital and maximizing cash generation. In addition, we will continue to focus on tax efficiency. We believe our global effective tax rate will approximate 12% this year, but will vary based on the locales in which incremental income is actually earned. We increased our quarterly dividend by 4% in 2009 to $0.125 per share. Under our existing share repurchase program, we have the ability to periodically repurchase shares in 2009. In addition, we remain committed to evaluating the merits of any opportunities that may arise for acquisitions that complement our business footprint.

In late September 2009, we initiated the consultation process with our employees at our EU headquarters in Brussels, and with the respective works councils at our Martinswerk plant in Germany and our refinery catalyst center in the Netherlands. These consultations are required under local laws prior to any restructuring at those sites. We are unable at this stage in the consultation to predict the timing or amount of any charge related to any restructurings, but we estimate charges could be in the range of $10 to $15 million in future quarters.

Additional information regarding our products, markets and financial performance is provided at our web site, www.albemarle.com. Our web site is not a part of this document nor is it incorporated herein by reference.

 

16


Table of Contents

Results of Operations

The following data and discussion provides an analysis of certain significant factors affecting our results of operations during the periods included in the accompanying consolidated statements of income.

Third Quarter 2009 Compared with Third Quarter 2008

Selected Financial Data (Unaudited)

 

     Three Months Ended
September 30,
    Percentage
Change
 
     2009     2008     2009 vs. 2008  
     (In millions, except percentages and per share amounts)  

NET SALES

   $ 515.3      $ 660.5      (22 )% 

Cost of goods sold

     381.2        506.3      (25 )% 
                      

GROSS PROFIT

     134.1        154.2      (13 )% 

GROSS PROFIT MARGIN

     26.0     23.3  

Selling, general and administrative expenses

     56.2        59.9      (6 )% 

Research and development expenses

     15.0        17.4      (14 )% 
                      

OPERATING PROFIT

     62.9        76.9      (18 )% 

OPERATING PROFIT MARGIN

     12.2     11.6  

Interest and financing expenses

     (6.2     (9.8   (37 )% 

Other income (expenses), net

     0.3        (2.7   *   
                      

INCOME BEFORE INCOME TAXES AND EQUITY IN NET INCOME OF UNCONSOLIDATED INVESTMENTS

     57.0        64.4      (11 )% 

Income tax expense

     (5.5     (9.9   (44 )% 

Effective tax rate

     9.7     15.3  
                      

INCOME BEFORE EQUITY IN NET INCOME OF UNCONSOLIDATED INVESTMENTS

     51.5        54.5      (6 )% 

Equity in net income of unconsolidated investments (net of tax)

     5.8        6.3      (8 )% 
                      

NET INCOME

     57.3        60.8      (6 )% 

Net income attributable to noncontrolling interests

     (5.2     (4.6   13
                      

NET INCOME ATTRIBUTABLE TO ALBEMARLE CORPORATION

   $ 52.1      $ 56.2      (7 )% 
                      

PERCENTAGE OF NET SALES

     10.1     8.5  
                      

Basic earnings per share

   $ 0.57      $ 0.61      (7 )% 
                      

Diluted earnings per share

   $ 0.57      $ 0.61      (7 )% 
                      

 

*  Calculation is not meaningful.

     

Net Sales

For the three-month period ended September 30, 2009, we recorded net sales of $515.3 million, a 22% decrease compared to net sales of $660.5 million for the three-month period ended September 30, 2008. This decrease was due primarily to a decline in volumes in all segments. Volumes had a negative impact on sales of 12%, price and product mix caused a 9% decrease and foreign currency changes had an unfavorable impact of 1% compared to the same period last year.

Polymer Additives net sales decreased $65.0 million, or 25%, for the three-month period ended September 30, 2009 compared to the same period in 2008, with volumes contributing 17% of the decrease, price and product mix impacts of 6% and foreign currency impacts of 2%. Catalysts net sales decreased $42.7 million, or 18%, compared to the same period last year due mainly to price and mix impacts of 14%, a decrease in volumes contributing 3%, and foreign currency impacts of 1%. Fine Chemicals net sales decreased $37.5 million, or 22%, compared to the same period last year primarily due to volumes contributing 16% of the decrease, price and product mix impacts of 5% and foreign currency impacts of 1%. For a detailed discussion of revenues and segment income before taxes for each segment see “Segment Information Overview” below.

 

17


Table of Contents

Gross Profit

For the three-month period ended September 30, 2009, our gross profit decreased $20.1 million, or 13%, to $134.1 million from the corresponding 2008 period due mainly to volume declines and unfavorable production rate impacts on cost in our bromine franchise. During the three-month period ended September 30, 2009, we continued to operate our manufacturing facilities at reduced production rates to control inventory levels, contributing to unfavorable profit effects from lower fixed cost absorption. Our gross profit margin improved for the three-month period ended September 30, 2009 to 26.0% from 23.3% for the corresponding period in 2008.

Selling, General and Administrative Expenses

For the three-month period ended September 30, 2009, our selling, general and administrative, or SG&A, expenses decreased $3.7 million, or 6%, from the three-month period ended September 30, 2008. This decrease was primarily due to a reduction in discretionary spending and personnel costs as a result of our recent cost saving actions. As a percentage of net sales, SG&A expenses were 10.9% for the three-month period ended September 30, 2009 compared to 9.1% for the corresponding period in 2008.

Research and Development Expenses

For the three-month period ended September 30, 2009, our research and development, or R&D, expenses decreased $2.4 million, or 14%, from the three-month period ended September 30, 2008. This decrease was primarily due to a reduction in personnel costs. As a percentage of net sales, R&D expenses were 2.9% for the three-month period ended September 30, 2009 compared to 2.6% for the corresponding period in 2008.

Interest and Financing Expenses

Interest and financing expenses for the three-month period ended September 30, 2009 decreased $3.6 million to $6.2 million from the corresponding 2008 period due to both lower average interest rates and average debt levels.

Other Income (Expenses), Net

Other income (expenses), net for the three-month period ended September 30, 2009 increased $3.0 million from the corresponding 2008 period due primarily to a decrease in foreign currency exchange losses.

Income Tax Expense

For the three-month period ended September 30, 2009, our effective income tax rate was 9.7% as compared to 15.3% for the three-month period ended September 30, 2008. The effective income tax rate for the three-month period ended September 30, 2009 was impacted by jurisdictional mix and levels of income projected for 2009. Based on our current level and location of income, we anticipate that our effective tax rate for 2009, excluding non-recurring items, will approximate 12%.

The significant differences between the U.S. federal statutory income tax rate on pretax income and the effective income tax rate for the three-month periods ended September 30, 2009 and 2008 are as follows:

 

     % of Income Before Income Taxes  
     Three Months Ended
September 30,
 
     2009     2008  

Federal statutory rate

   35.0   35.0

State taxes, net of federal tax benefit

   0.3      0.4   

Impact of foreign operations, net

   (24.7   (18.4

Increase in valuation allowance

   0.5      1.8   

Depletion

   (0.9   (1.7

Effect of net income attributable to noncontrolling interests

   (0.9   (0.7

Revaluation of unrecognized tax benefits/reserve requirements

   0.4      1.5   

Other items, net

   —        (2.6
            

Effective income tax rate

   9.7   15.3
            

 

18


Table of Contents

Equity in Net Income of Unconsolidated Investments

Equity in net income of unconsolidated investments was $5.8 million for the three-month period ended September 30, 2009 compared to $6.3 million in the same period last year. This decrease was due primarily to lower equity earnings from our Catalysts segment joint venture, Nippon Ketjen Company Limited, as a result of unfavorable material input costs.

Net Income Attributable to Noncontrolling Interests

For the three-month period ended September 30, 2009, net income attributable to noncontrolling interests was $5.2 million compared to $4.6 million in the same period last year. This increase was associated with Jordan Bromine Company Limited.

Net Income Attributable to Albemarle Corporation

Net income attributable to Albemarle Corporation decreased to $52.1 million in the three-month period ended September 30, 2009, from $56.2 million in the three-month period ended September 30, 2008, primarily due to volume declines across our businesses partially offset by reduced fixed manufacturing and SG&A cost spending as a result of our recent cost saving actions and less interest expense due to lower average interest rates and debt levels.

Segment Information Overview. We have identified three reportable segments. Our Polymer Additives segment is comprised of the flame retardants and stabilizers and curatives product areas. Our Catalysts segment is comprised of the refinery catalysts and polyolefin catalysts product areas. Our Fine Chemicals segment is comprised of the performance chemicals and fine chemistry services and intermediates product areas. Segment income represents operating profit (adjusted for significant non-recurring items) and equity in net income of unconsolidated investments and is reduced by net income attributable to noncontrolling interests. Segment data includes intersegment transfers of raw materials at cost, foreign exchange transaction gains and losses and allocations for certain corporate costs.

 

19


Table of Contents
     Three Months Ended September 30,     Percentage
Change
 
     2009     % of
net sales
    2008     % of
net sales
    2009 vs 2008  
     (In millions, except percentages)  

Net sales:

          

Polymer Additives

   $ 196.7      38.2   $ 261.7      39.6   (25 )% 

Catalysts

     188.9      36.6     231.6      35.1   (18 )% 

Fine Chemicals

     129.7      25.2     167.2      25.3   (22 )% 
                              

Total net sales

   $ 515.3      100.0   $ 660.5      100.0   (22 )% 
                              

Segment operating profit:

          

Polymer Additives

   $ 27.2      13.8   $ 28.7      11.0   (5 )% 

Catalysts

     28.9      15.3     31.0      13.4   (7 )% 

Fine Chemicals

     16.4      12.6     26.8      16.0   (39 )% 
                      

Subtotal

   $ 72.5        $ 86.5        (16 )% 
                      

Equity in net income of unconsolidated investments:

          

Polymer Additives

   $ 1.3        $ 0.8        63

Catalysts

     4.5          5.5        (18 )% 

Fine Chemicals

     —            —          —  

Corporate & other

     —            —          —  
                      

Total equity in net income of unconsolidated investments

   $ 5.8        $ 6.3        (8 )% 
                      

Net (income) loss attributable to noncontrolling interests:

          

Polymer Additives

   $ (2.5     $ (2.1     19

Catalysts

     —            —          —  

Fine Chemicals

     (2.2       (2.1     5

Corporate & other

     (0.5       (0.4     25
                      

Total net income attributable to noncontrolling interests

   $ (5.2     $ (4.6     13
                      

Segment income:

          

Polymer Additives

   $ 26.0      13.2   $ 27.4      10.5   (5 )% 

Catalysts

     33.4      17.7     36.5      15.8   (8 )% 

Fine Chemicals

     14.2      10.9     24.7      14.8   (43 )% 
                      

Total segment income

     73.6          88.6        (17 )% 

Corporate & other

     (10.1       (10.0     1

Interest and financing expenses

     (6.2       (9.8     (37 )% 

Other income (expenses), net

     0.3          (2.7     *   

Income tax expense

     (5.5       (9.9     (44 )% 
                      

Net income attributable to Albemarle Corporation

   $ 52.1        $ 56.2        (7 )% 
                      

 

* Calculation is not meaningful.

 

20


Table of Contents

Polymer Additives

Polymer Additives segment net sales for the three-month period ended September 30, 2009 were $196.7 million, down $65.0 million, or 25%, versus the three-month period ended September 30, 2008. This decline is a result of a decrease in volumes primarily in our flame retardants portfolio as a result of softness in the consumer electronics, automotive and construction sectors. Segment income was down 5%, or $1.4 million, to $26.0 million due mainly to unfavorable product mix in our flame retardants portfolio and stabilizers and curatives business, lower sales volumes in our flame retardants portfolio, partially offset by improvements in raw materials and other operating costs for the three-month period ended September 30, 2009, as compared to the same period in 2008.

Catalysts

Catalysts segment net sales for the three-month period ended September 30, 2009 were $188.9 million, a decrease of $42.7 million, or 18%, versus the three-month period ended September 30, 2008. This decrease was due primarily to unfavorable metals impacts on HPC refinery catalysts revenues, foreign currency exchange rates and less favorable product mix in polyolefin catalysts. Segment income decreased 8%, or $3.1 million, to $33.4 million for the three-month period ended September 30, 2009 compared to the same period in 2008, due mainly to lower equity income, unfavorable foreign currency exchange rates, metals impacts on HPC refinery catalysts, and lower fixed cost absorption in polyolefin catalysts.

Fine Chemicals

Fine Chemicals segment net sales for the three-month period ended September 30, 2009 were $129.7 million, a decrease of $37.5 million, or 22%, versus the three-month period ended September 30, 2008. This decrease was due mainly to lower volumes in our completion fluids business for oil drilling in industrial bromides and reduced volumes in fine chemistry services. Segment income for the three-month period ended September 30, 2009 was $14.2 million, down $10.5 million, or 43%, from the three-month period ended September 30, 2008, due primarily to our industrial bromides business.

Corporate and other

For the three-month period ended September 30, 2009, our Corporate and other expenses increased nominally from the three-month period ended September 30, 2008.

 

21


Table of Contents

Nine-Months 2009 Compared with Nine-Months 2008

Selected Financial Data (Unaudited)

 

     Nine Months Ended
September 30,
    Percentage
Change
 
     2009     2008     2009 vs. 2008  
     (In millions, except percentages and per
share amounts)
 

NET SALES

   $ 1,447.2      $ 1,949.4      (26 )% 

Cost of goods sold

     1,112.8        1,464.8      (24 )% 
                      

GROSS PROFIT

     334.4        484.6      (31 )% 

GROSS PROFIT MARGIN

     23.1     24.9  

Selling, general and administrative expenses

     153.1        191.0      (20 )% 

Research and development expenses

     46.1        51.8      (11 )% 

Port de Bouc charges

     12.4        —        *   

Restructuring charges

     —          3.3      *   
                      

OPERATING PROFIT

     122.8        238.5      (49 )% 

OPERATING PROFIT MARGIN

     8.5     12.2  

Interest and financing expenses

     (18.6     (28.5   (35 )% 

Other income, net

     0.5        2.1      (76 )% 
                      

INCOME BEFORE INCOME TAXES AND EQUITY IN NET INCOME OF UNCONSOLIDATED INVESTMENTS

     104.7        212.1      (51 )% 

Income tax benefit (expense)

     1.7        (39.4   *   

Effective tax rate

     (1.6 )%      18.6  
                      

INCOME BEFORE EQUITY IN NET INCOME OF UNCONSOLIDATED INVESTMENTS

     106.4        172.7      (38 )% 

Equity in net income of unconsolidated investments (net of tax)

     18.0        22.0      (18 )% 
                      

NET INCOME

     124.4        194.7      (36 )% 

Net income attributable to noncontrolling interests

     (8.4     (13.6   (38 )% 
                      

NET INCOME ATTRIBUTABLE TO ALBEMARLE CORPORATION

   $ 116.0      $ 181.1      (36 )% 
                      

PERCENTAGE OF NET SALES

     8.0     9.3  
                      

Basic earnings per share

   $ 1.27      $ 1.97      (36 )% 
                      

Diluted earnings per share

   $ 1.26      $ 1.95      (35 )% 
                      

 

*  Calculation is not meaningful.

     

Net Sales

For the nine-month period ended September 30, 2009, we recorded net sales of $1,447.2 million, a 26% decrease compared to net sales of $1,949.4 million for the nine-month period ended September 30, 2008. This decrease was due primarily to a decline in volumes in all segments. Volumes had a negative impact on sales of 20% and price and product mix as well as foreign currency changes each caused a 3% decrease compared to the same period last year.

Polymer Additives net sales decreased $274.1 million, or 36%, for the nine-month period ended September 30, 2009, compared to the same period in 2008, as a result of volumes contributing 31% of the decrease, foreign currency impacts of 3% and price and product mix impacts of 2%. Catalysts net sales decreased $116.0 million, or 16%, compared to the same period last year due mainly to a decrease in volumes contributing 8%, price and product mix impacts of 5% and foreign currency impacts of 3%. Fine Chemicals net sales decreased $112.1 million, or 24%, compared to the same period last year with decreased volumes causing 22% of the decline and foreign currency impacts of 2%. For a detailed discussion of revenues and segment income before taxes for each segment see “Segment Information Overview” below.

Gross Profit

For the nine-month period ended September 30, 2009, our gross profit decreased $150.2 million, or 31%, to $334.4 million from the corresponding 2008 period, due mainly to volume declines, unfavorable production rate impacts on cost in

 

22


Table of Contents

our bromine franchise and high cost metals impacts on HPC refinery catalysts. During the nine-month period ended September 30, 2009, we operated our manufacturing facilities at reduced rates to control inventory levels, contributing to unfavorable profit effects from lower fixed cost absorption. These factors contributed to our decline in gross profit margin for the nine-month period ended September 30, 2009 to 23.1% from 24.9% for the corresponding period in 2008.

Selling, General and Administrative Expenses

For the nine-month period ended September 30, 2009, our SG&A expenses decreased $37.9 million, or 20%, from the nine-month period ended September 30, 2008. This decrease was primarily due to a reduction in personnel costs and discretionary spending resulting from our recent cost saving actions and first quarter 2009 adjustments of $7.0 million associated with the reversal of certain long-term employee benefit accruals. As a percentage of net sales, SG&A expenses were 10.6% for the nine-month period ended September 30, 2009 compared to 9.8% for the corresponding period in 2008.

Research and Development Expenses

For the nine-month period ended September 30, 2009, our R&D expenses decreased $5.7 million, or 11%, from the nine-month period ended September 30, 2008. This decrease was primarily due to a reduction in personnel costs. As a percentage of net sales, R&D expenses were 3.2% for the nine-month period ended September 30, 2009 compared to 2.7% for the corresponding period in 2008.

Port de Bouc Charges

The nine-month period ended September 30, 2009 includes charges amounting to $12.4 million ($8.2 million after income taxes) that related to the costs of a final contract settlement arising from the 2008 divestiture of the Port de Bouc, France facility.

Restructuring Charges

The nine-month period ended September 30, 2008 includes charges amounting to $3.3 million ($2.1 million after income taxes) that related to severance costs in conjunction with personnel reductions at our former Richmond, Virginia headquarters and our Singapore sales office.

Interest and Financing Expenses

Interest and financing expenses for the nine-month period ended September 30, 2009 decreased $9.9 million to $18.6 million from the corresponding 2008 period primarily due to lower average interest rates.

Other Income, Net

Other income, net for the nine-month period ended September 30, 2009 decreased $1.6 million from the corresponding 2008 period due primarily to a decrease in interest income as a result of lower average interest rates.

Income Tax Benefit (Expense)

Our effective income tax rate was (1.6)% and 18.6% for the nine-month periods ended September 30, 2009 and 2008, respectively. The effective income tax rate for the nine-month period ended September 30, 2009 was impacted by various non-recurring items totaling a net benefit of $15.7 million. Included in this amount is a net $9.2 million benefit due mainly to decreases in unrecognized tax benefit liabilities and deferred tax assets related to an issue settled in the current U.S. IRS examination of years 2005 through 2007 and a net $4.2 million benefit related to the charges arising out of our divestiture of the Port de Bouc, France facility. Also included is a $3.7 million benefit due mainly to unrecognized tax benefits, partially offset by a $1.2 million increase in a valuation allowance for losses at our Brazilian subsidiary. Based on our current level and location of income, we anticipate that our effective tax rate for 2009, excluding non-recurring items, will approximate 12%.

 

23


Table of Contents

The significant differences between the U.S. federal statutory income tax rate on pretax income and the effective income tax rate for the nine-month periods ended September 30, 2009 and 2008 are as follows:

 

     % of Income Before Income Taxes  
     Nine Months Ended
September 30,
 
     2009     2008  

Federal statutory rate

   35.0   35.0

State taxes, net of federal tax benefit

   0.3      0.4   

Impact of foreign operations, net

   (24.0   (15.5

Increase in valuation allowance

   1.6      0.6   

Depletion

   (1.3   (1.5

Effect of net income attributable to noncontrolling interests

   (0.8   (0.6

Revaluation of unrecognized tax benefits/reserve requirements

   (11.5   1.2   

Other items, net

   (0.9   (1.0
            

Effective income tax rate

   (1.6 )%    18.6
            

Equity in Net Income of Unconsolidated Investments

Equity in net income of unconsolidated investments was $18.0 million for the nine-month period ended September 30, 2009 compared to $22.0 million in the same period last year. This decrease of $4.0 million is due primarily to lower overall equity earnings from our various Catalysts segment joint ventures as well as lower equity earnings from our Magnifin joint venture in our Polymer Additives segment due to decreased volumes in the automotive sector.

Net Income Attributable to Noncontrolling Interests

For the nine-month period ended September 30, 2009, net income attributable to noncontrolling interests was $8.4 million compared to $13.6 million in the same period last year. This decrease of $5.2 million is due primarily to lower earnings of Jordan Bromine Company Limited resulting from lower bromine volumes as well as lower earnings of Stannica LLC due to volume impacts from demand softness in the construction sector.

Net Income Attributable to Albemarle Corporation

Net income attributable to Albemarle Corporation decreased to $116.0 million in the nine-month period ended September 30, 2009 from $181.1 million in the nine-month period ended September 30, 2008 primarily due to volume declines and unfavorable fixed cost absorption across our businesses, high cost metals impacts on HPC refinery catalysts, and Port de Bouc related charges of $12.4 million. These impacts were partially offset by reduced fixed manufacturing and SG&A cost spending as a result of our recent cost saving actions, a decline in interest and financing expenses, and various non-recurring tax items.

 

24


Table of Contents

Segment Information Overview

 

     Nine Months Ended September 30,     Percentage
Change
 
     2009     % of
net sales
    2008     % of
net sales
    2009 vs 2008  
     (In millions, except percentages)  

Net sales:

          

Polymer Additives

   $ 492.7      34.0   $ 766.8      39.4   (36 )% 

Catalysts

     600.1      41.5     716.1      36.7   (16 )% 

Fine Chemicals

     354.4      24.5     466.5      23.9   (24 )% 
                              

Total net sales

   $ 1,447.2      100.0   $ 1,949.4      100.0   (26 )% 
                              

Segment operating profit:

          

Polymer Additives

   $ 31.6      6.4   $ 86.3      11.3   (63 )% 

Catalysts

     90.3      15.0     112.6      15.7   (20 )% 

Fine Chemicals

     32.5      9.2     78.0      16.7   (58 )% 
                      

Subtotal

   $ 154.4        $ 276.9        (44 )% 
                      

Equity in net income of unconsolidated investments:

          

Polymer Additives

   $ 1.6        $ 3.5        (54 )% 

Catalysts

     16.5          18.6        (11 )% 

Fine Chemicals

     —            —          —  

Corporate & other

     (0.1       (0.1     —  
                      

Total equity in net income of unconsolidated investments

   $ 18.0        $ 22.0        (18 )% 
                      

Net (income) loss attributable to noncontrolling interests:

          

Polymer Additives

   $ (4.2     $ (6.2     (32 )% 

Catalysts

     —            —          —  

Fine Chemicals

     (4.4       (7.3     (40 )% 

Corporate & other

     0.2          (0.1     *   
                      

Total net income attributable to noncontrolling interests

   $ (8.4     $ (13.6     (38 )% 
                      

Segment income:

          

Polymer Additives

   $ 29.0      5.9   $ 83.6      10.9   (65 )% 

Catalysts

     106.8      17.8     131.2      18.3   (19 )% 

Fine Chemicals

     28.1      7.9     70.7      15.2   (60 )% 
                      

Total segment income

     163.9          285.5        (43 )% 

Corporate & other

     (19.1       (35.3     (46 )% 

Port de Bouc charges

     (12.4       —          *   

Restructuring charges

     —            (3.3     *   

Interest and financing expenses

     (18.6       (28.5     (35 )% 

Other income, net

     0.5          2.1        (76 )% 

Income tax benefit (expense)

     1.7          (39.4     *   
                      

Net income attributable to Albemarle Corporation

   $ 116.0        $ 181.1        (36 )% 
                      

 

* Calculation is not meaningful.

 

25


Table of Contents

Polymer Additives

Polymer Additives segment net sales for the nine-month period ended September 30, 2009 were $492.7 million, down $274.1 million, or 36%, versus the nine-month period ended September 30, 2008. This decline was a result of a decrease in volumes primarily in our flame retardants portfolio as a result of softness in the consumer electronics, automotive and construction sectors. Net sales also declined in our stabilizers and curatives product lines primarily due to reduced volumes, unfavorable product mix and raw material pass through impacts. Segment income declined 65%, or $54.6 million, to $29.0 million due mainly to lower sales volumes as well as lower production volumes which contributed to unfavorable fixed cost absorption, unfavorable product mix in stabilizers and curatives and the impact of foreign currency exchange rates for the nine-month period ended September 30, 2009, as compared to the nine-month period ended September 30, 2008.

Catalysts

Catalysts segment net sales for the nine-month period ended September 30, 2009 were $600.1 million, a decrease of $116.0 million, or 16%, versus the nine-month period ended September 30, 2008. This decrease was due primarily to unfavorable metals impacts on HPC refinery catalysts revenues, foreign currency exchange rates and lower FCC refinery catalysts volumes, and is partially offset by improved pricing in FCC refinery catalysts and Polyolefin catalysts. Segment income decreased 19%, or $24.4 million, to $106.8 million for the nine-month period ended September 30, 2009 compared to the same period in 2008, due mainly to unfavorable metals impacts on HPC refinery catalysts.

Fine Chemicals

Fine Chemicals segment net sales for the nine-month period ended September 30, 2009 were $354.4 million, a decrease of $112.1 million, or 24%, versus the nine-month period ended September 30, 2008. Segment income for the nine-month period ended September 30, 2009 was $28.1 million, down $42.6 million, or 60%, from the nine-month period ended September 30, 2008. These declines were due mainly to reduced sales and production volumes in the segment as well as unfavorable foreign currency exchange rates.

Corporate and other

For the nine-month period ended September 30, 2009, our Corporate and other expenses decreased $16.2 million, or 46%, to $19.1 million from the nine-month period ended September 30, 2008. This decrease was primarily due to first quarter 2009 adjustments of $7.8 million associated with the reversal of certain long-term employee benefit accruals. This adjustment is primarily included in “Selling, general and administrative expenses” in our consolidated statements of income. In addition, the nine-month period ended September 30, 2009 includes further cost savings associated with employee related expenses.

Financial Condition and Liquidity

Overview

The principal uses of cash in our business generally have been investment in our assets, funding working capital and repayment of debt. In 2008, we made a $25.0 million voluntary contribution to our U.S. defined benefit pension plans. Historically, cash to fund the needs of our business has been principally provided by cash from operations, debt financing and equity issuances.

We are continuing our program to improve working capital efficiency and metrics particularly in the areas of accounts receivable and inventory. We expect the combination of our current cash balances and availability under our March 2007 credit agreement, which is discussed below, to remain sufficient to fund working capital requirements for the foreseeable future.

Cash Flow

Our cash balance increased by $7.1 million to $260.4 million at September 30, 2009 from $253.3 million at December 31, 2008. For the nine-month period ended September 30, 2009, our operations provided $259.4 million of cash compared to $161.8 million in the nine-month period ended September 30, 2008. This increase of $97.6 million, despite a $70.3 million decrease in net income, was due mainly to improved working capital performance. Cash flow from operations funded capital expenditures for plant, machinery and equipment of $83.6 million, net repayments of long-term debt of $113.1 million and dividends to shareholders of $33.3 million.

 

26


Table of Contents

Net current assets decreased $79.7 million to $660.9 million at September 30, 2009 from $740.6 million at December 31, 2008. The decrease in net current assets was due primarily to a decrease in inventory, partially offset by a decrease in accounts payable and accrued expenses.

Capital expenditures of $83.6 million for the nine-month period ended September 30, 2009 were associated with plant, machinery and equipment improvements. We expect our capital expenditures to be approximately $95 to $100 million in 2009 mainly due to increases in plant, machinery and equipment in our Catalysts and Fine Chemicals segments. However, we continue to closely monitor our capital spending in light of the global economic situation and our cash generation. We anticipate that future capital expenditures will be financed primarily with cash flow provided from operations with additional cash needed, if any, provided by borrowings including amounts available under our March 2007 credit agreement. The amount and timing of any additional borrowings will depend on our specific cash requirements.

Long-Term Debt

We currently have outstanding $325.0 million of 5.10% senior notes due in 2015. The senior notes are senior unsecured obligations and rank equally with all of our other senior unsecured indebtedness outstanding from time to time. The senior notes will be effectively subordinated to any of our future secured indebtedness and to the existing and future indebtedness of our subsidiaries. We may redeem the senior notes before their maturity, in whole at any time or in part from time to time, at a redemption price equal to the greater of (1) 100% of the principal amount of the senior notes to be redeemed or (2) the sum of the present values of the remaining scheduled payments of principal and interest thereon (exclusive of interest accrued to the date of redemption) discounted to the redemption date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate (as defined in the indenture governing the senior notes) plus 15 basis points, plus, in each case, accrued interest thereon to the date of redemption.

The principal amount of the senior notes becomes immediately due and payable upon the occurrence of certain bankruptcy or insolvency events involving us or certain of our subsidiaries and may be declared immediately due and payable by the trustee or the holders of not less than 25% of the senior notes upon the occurrence of an event of default. Events of default include, among other things: failure to pay principal or interest at required times; failure to perform or remedy a breach of covenants within prescribed periods; an event of default on any of our other indebtedness or certain indebtedness of our subsidiaries of $40.0 million or more that is caused by a failure to make a payment when due or that results in the acceleration of that indebtedness before its maturity; and certain bankruptcy or insolvency events involving us or certain of our subsidiaries. We believe that as of September 30, 2009, we were, and currently are, in compliance with all of the covenants of the indenture governing the senior notes.

For additional funding and liquidity purposes, we currently maintain a $675.0 million five-year unsecured revolving senior credit facility, which we refer to as the March 2007 credit agreement. The March 2007 credit agreement provides for an additional $200.0 million in credit, if needed, upon additional loan commitments by our existing and/or additional lenders. The total spreads and fees can range from 0.32% to 0.675% over the London inter-bank offered rate, or LIBOR, applicable to the currency of denomination of the borrowing and are based upon our credit rating from one of the major credit rating agencies. There were aggregate borrowings outstanding under the March 2007 credit agreement of $395.0 million at September 30, 2009. Borrowings under the March 2007 credit agreement bear interest at variable rates, which was a weighted average of 0.6% during the three-month period ended September 30, 2009.

In March 2008, we exercised an option under the March 2007 credit agreement to extend the maturity date from March 2012 to March 2013. Lenders representing 87.4% of the commitments, or $590 million out of $675 million, approved the extension. No other changes to the agreement were part of the extension, and no fees, other than attorney fees, were paid. As a result of the extension, approximately $85 million and $590 million in commitments now have a maturity/expiration date of March 2012 and March 2013, respectively.

Borrowings under our March 2007 credit agreement are conditioned upon compliance with the following covenants: (a) consolidated funded debt, as defined in the March 2007 credit agreement, must be less than or equal to 3.50 times consolidated EBITDA, as defined in the March 2007 credit agreement, as of the end of any fiscal quarter; (b) consolidated tangible domestic assets, as defined in the March 2007 credit agreement, must be greater than or equal to $750.0 million for us to make investments in entities and enterprises that are organized outside the U.S.; and (c) with the exception of liens specified in our March 2007 credit agreement, liens may not attach to assets when the aggregate amount of all indebtedness secured by such liens plus unsecured indebtedness, other than indebtedness incurred by our subsidiaries under the March 2007 credit agreement would exceed 20% of consolidated net worth, as defined in the March 2007 credit agreement. We believe that as of September 30, 2009, we were, and currently are, in compliance with all of the debt covenants under the March 2007 credit agreement.

 

27


Table of Contents

The non-current portion of our long-term debt amounted to $793.1 million at September 30, 2009, compared to $906.1 million at December 31, 2008. In addition, at September 30, 2009, we had the ability to borrow $280.0 million under our March 2007 credit agreement and $187.6 million under other existing lines of credit, subject to various financial covenants under our March 2007 credit agreement.

Off-Balance Sheet Arrangements

In the normal course of business with customers, vendors and others, we have entered into off-balance sheet arrangements, including bank guarantees and letters of credit which totaled approximately $31.5 million at September 30, 2009. None of these off-balance sheet arrangements either has, or is likely to have, a material effect on our current or future financial condition, results of operations, liquidity or capital resources.

Other Obligations

The following table summarizes our contractual obligations for plant construction, purchases of equipment and various take or pay and throughput agreements (in thousands):

 

     4Q 2009    2010    2011    2012    2013    2014    There-
after

Long-term debt obligations

   $ 16,170    $ 8,419    $ 5,017    $ 7,421    $ 433,193    $ 6,014    $ 332,978

Capital lease obligation

     1,801      3,758      3,975      2,073      —        —        —  

Expected interest payments on long-term debtobligations*

     6,376      24,960      26,618      29,223      22,188      19,128      2,808

Operating lease obligations (rental)

     2,383      7,848      5,470      3,905      2,527      2,261      15,830

Take or pay / throughput agreements**

     36,828      28,411      11,139      5,213      5,137      3,733      6,958

Letters of credit and guarantees

     11,110      13,239      2,493      1,524      553      —        2,553

Capital projects

     13,363      5,202      1,077      —        —        —        —  

Facility divestiture obligation

     583      —        —        —        —        —        —  

Additional investment commitment payments

     45      —        —        —        —        —        —  
                                                

Total

   $ 88,659    $ 91,837    $ 55,789    $ 49,359    $ 463,598    $ 31,136    $ 361,127
                                                

 

* These amounts are based on a weighted-average interest rate of 0.6% for the March 2007 credit agreement, 5.1% for the senior notes, and 4.1% for our remaining long-term debt obligations and capital lease for 2009. The weighted average interest rate for years 2010 and thereafter is 1.9% for the March 2007 credit agreement, 5.1% for the senior notes, and 5.3% for our remaining long-term debt obligations and capital lease.
** These amounts primarily relate to contracts entered into with certain third party vendors in the normal course of business to secure raw materials for our production processes. In order to secure materials, sometimes for long durations, these contracts mandate a minimum amount of product to be purchased at predetermined rates over a set timeframe.

Amounts in the table above exclude required employer pension contributions. We have determined that the expected required 2009 contributions to our domestic nonqualified and foreign qualified and nonqualified pension plans should approximate $11 million. We have made $2.4 million and $8.1 million in contributions to our qualified and nonqualified pension plans during the three-month and nine-month periods ended September 30, 2009, respectively. We estimate that the domestic qualified pension plan contributions could approximate $40 million over the next twelve months, a portion of which we may choose to fund before the end of 2009.

We are subject to federal, state, local, and foreign requirements regulating the handling, manufacture and use of materials (some of which may be classified as hazardous or toxic by one or more regulatory agencies), the discharge of materials into the environment and the protection of the environment. To our knowledge, we are currently complying and expect to continue to comply in all material respects with applicable environmental laws, regulations, statutes and ordinances. Compliance with existing federal, state, local, and foreign environmental protection laws is not expected to have a material effect on earnings or our competitive position, but the costs associated with increased legal or regulatory requirements could have an adverse effect on our results.

Among other environmental requirements, we are subject to the federal Superfund law, and similar state laws, under which we may be designated as a potentially responsible party, or PRP, and may be liable for a share of the costs associated with cleaning up various hazardous waste sites. Management believes that in most cases, our participation is de minimis. Further, almost all such sites represent environmental issues that are quite mature and have been investigated, studied and in

 

28


Table of Contents

many cases settled. In de minimis situations, our policy generally is to negotiate a consent decree and to pay any apportioned settlement, enabling us to be effectively relieved of any further liability as a PRP, except for remote contingencies. In other than de minimis PRP matters, our records indicate that unresolved PRP exposures should be immaterial. We accrue and expense our proportionate share of PRP costs. Because management has been actively involved in evaluating environmental matters, we are able to conclude that the outstanding environmental liabilities for unresolved PRP sites should not be material to operations.

Liquidity Outlook

We anticipate that cash provided from operating activities in the future and borrowings under our March 2007 credit agreement will be sufficient to pay our operating expenses, satisfy debt service obligations, fund capital expenditures and pension contributions, and make dividend payments for the foreseeable future. In addition, as we have historically done, we will continue to evaluate the merits of any opportunities that may arise for acquisitions of businesses or assets, which may require additional liquidity.

While we maintain business relationships with a diverse group of financial institutions, their continued viability is not certain and could lead them to not honor their contractual credit commitments or to not renew their extensions of credit or provide new sources of credit. Recently, the capital markets have shown signs of stabilizing after several quarters of volatility caused by adverse conditions that have lead to the consolidation, failure and near failure of a number of large financial services companies. Nevertheless, if the capital markets return to recent volatility, we may incur increased costs associated with borrowings. In that event, our ability to access the capital markets may be limited at a time when we would need or desire to do so, which could have an impact on our ability to finance our businesses or react to changing economic and business conditions. In addition, our cash flows from operations may be adversely affected by adverse consequences to our customers and the markets in which we compete as a result of the current financial, economic, and capital market conditions and uncertainty.

At September 30, 2009, we had the ability to borrow in excess of $465 million under our March 2007 credit agreement and other existing lines of credit, subject to various financial covenants under our March 2007 credit agreement. With generally strong cash generative businesses and no significant debt maturities before 2013, we believe we have a solid liquidity position.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

There have been no significant changes in our interest rate risk, foreign currency exchange rate exposure, marketable securities price risk, or raw material price risk from the information we provided in the Annual Report on Form 10-K for the year ended December 31, 2008 except as noted below.

We had outstanding variable interest rate borrowings at September 30, 2009 of $441.7 million, bearing an average interest rate of 0.81%. A hypothetical 10% change (approximately 8 basis points) in the interest rate applicable to these borrowings would change our annualized interest expense by approximately $0.4 million as of September 30, 2009. We may enter into interest rate swaps, collars or similar instruments with the objective of reducing interest rate volatility relating to our borrowing costs.

Our financial instruments, which are subject to foreign currency exchange risk, consist of foreign currency forward contracts and represented a net liability position of $0.2 million at September 30, 2009. We conducted a sensitivity analysis on the fair value of our foreign currency hedge portfolio assuming instantaneous 10% changes in select foreign currency exchange rates from their levels as of September 30, 2009, with all other variables held constant. A 10% appreciation of the U.S. Dollar against foreign currencies that we have hedging contracts against would result in an increase of $0.8 million in the fair value of our foreign currency exchange hedging contracts. A 10% depreciation of the U.S. Dollar against these foreign currencies would result in a decrease of $1.4 million in the fair value of our foreign currency exchange hedging contracts. The sensitivity in fair value of our foreign currency hedge portfolio represents changes in fair values estimated based on market conditions as of September 30, 2009, without reflecting the effects of underlying anticipated transactions. When those anticipated transactions are realized, actual effects of changing foreign currency exchange rates could have a material impact on our earnings and cash flows in future periods.

In 2004, we entered into treasury lock agreements, or T-locks, with a notional value of $275.0 million, to fix the yield on the U.S. Treasury security used to set the yield for approximately 85% of our January 2005 public offering of the senior notes. The T-locks fixed the yield on the U.S. Treasury security at approximately 4.25%. The value of the T-locks resulted from the difference between (1) the yield-to-maturity of the 10-year U.S. Treasury security that had the maturity date most comparable to the maturity date of the senior notes issued and (2) the fixed rate of approximately 4.25%. The cumulative loss

 

29


Table of Contents

effect of the T-lock agreements was $2.2 million and is being amortized over the life of the senior notes as an adjustment to the senior notes’ interest expense. At September 30, 2009, there were losses of approximately $1.1 million ($0.7 million after income taxes) in accumulated other comprehensive loss that remain to be expensed.

In addition, certain of our operations use natural gas as a source of energy which can expose our business to market risk when the price of natural gas changes suddenly. In an attempt to mitigate the impact and volatility of price swings in the natural gas market, we purchase natural gas contracts, when appropriate, for a portion of our 12-month rolling forecast for North American natural gas requirements.

We also enter into natural gas hedge transactions from time to time with major financial institutions. Such derivatives are held to secure natural gas at fixed prices and not for trading. Our natural gas hedge contracts qualify as cash flow hedges and are marked to market. The unrealized gains and losses on these contracts are deferred and accounted for in accumulated other comprehensive loss to the extent that the unrealized gains and losses are offset by the forecasted transaction. At September 30, 2009, there were no natural gas hedge contracts outstanding and none were purchased in the three-month period ended September 30, 2009. Additionally, any unrealized gains and losses on the derivative instrument that are not offset by the forecasted transaction are recorded in earnings as appropriate, but generally do not have a significant impact on results of operations.

 

Item 4. Controls and Procedures.

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act), as of the end of the period covered by this report. Based on this evaluation, our principal executive officer and principal financial officer concluded that, as of end of the period covered by this report, our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act, is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

No change in our internal control over financial reporting (as such term is defined in Exchange Act Rule 13a-15(f)) occurred during the fiscal quarter ended September 30, 2009 that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings.

We are involved from time to time in legal proceedings of types regarded as common in our businesses, particularly administrative or judicial proceedings seeking remediation under environmental laws, such as Superfund, products liability and premises liability litigation. We maintain a financial accrual for these proceedings that includes defense costs and potential damages, as estimated by our general counsel. We also maintain insurance to mitigate certain of such risks. Additional information with respect to this Item 1 is contained in Note 10 to the Notes to the Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q.

 

Item 1A. Risk Factors.

While we attempt to identify, manage and mitigate risks and uncertainties associated with our business to the extent practical under the circumstances, some level of risk and uncertainty will always be present. Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2008 describes some of the risks and uncertainties associated with our business. These risks and uncertainties have the potential to materially affect our results of operations and our financial condition. We do not believe that there have been any material changes to the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2008.

 

30


Table of Contents
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

The following table summarizes our repurchases of equity securities for the three-month period ended September 30, 2009:

 

Period

   Total Number
of Shares
Repurchased
   Average Price
Paid Per share
   Total Number of Shares
Repurchased as Part of
Publicly Announced Plan
or Program *
   Maximum Number of
Shares that May Yet Be
Repurchased Under the
Plans or Programs *

July 1, 2009 to July 31, 2009

   —      —      —      4,400,000

August 1, 2009 to August 31, 2009

   —      —      —      4,400,000

September 1, 2009 to September 30, 2009

   —      —      —      4,400,000
                   

Total

   —      —      —      4,400,000
                   

 

* The stock repurchase plan, which was authorized by our Board of Directors, became effective on October 25, 2000 and included ten million shares. On February 27, 2008 after 98% of the originally authorized repurchase was executed, our Board of Directors approved an increase to five million shares authorized for repurchase under our stock repurchase plan. The stock repurchase plan will expire when we have repurchased all shares authorized for repurchase thereunder, unless the repurchase plan is earlier terminated by action of our Board of Directors or further shares are authorized for repurchase.

 

Item 6. Exhibits.

(a) Exhibits

 

31.1    Certification of Chief Executive Officer pursuant to Rule 13a-14(a)
31.2    Certification of Chief Financial Officer pursuant to Rule 13a-14(a)
32.1    Certification of Chief Executive Officer pursuant to Rule 13a-14(b) and 18 U.S.C. Section 1350
32.2    Certification of Chief Financial Officer pursuant to Rule 13a-14(b) and 18 U.S.C. Section 1350

 

31


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    ALBEMARLE CORPORATION
    (Registrant)
  Date: November 6, 2009     By:   /s/    RICHARD J. DIEMER, JR.        
       

Richard J. Diemer, Jr.

Senior Vice President and

Chief Financial Officer

(principal financial and accounting officer)

 

32

Exhbit 31.1

EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

I, Mark C. Rohr, certify that:

 

  1. I have reviewed this Quarterly Report on Form 10-Q of Albemarle Corporation for the period ended September 30, 2009;

 

  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

  4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with generally accepted accounting principles;

 

  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

  5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 6, 2009

 

/s/ MARK C. ROHR
Mark C. Rohr

Chairman of the Board, President, and

Chief Executive Officer

Exhibit 31.2

EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

I, Richard J. Diemer, Jr., certify that:

 

  1. I have reviewed this Quarterly Report on Form 10-Q of Albemarle Corporation for the period ended September 30, 2009;

 

  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

  4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with generally accepted accounting principles;

 

  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

  5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 6, 2009

 

/s/ RICHARD J. DIEMER, JR.
Richard J. Diemer, Jr.
Senior Vice President and Chief Financial Officer
Exhibit 32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Albemarle Corporation (the “Company”) for the period ended September 30, 2009 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mark C. Rohr, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

  (1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

  (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ MARK C. ROHR
Mark C. Rohr

Chairman of the Board, President, and

Chief Executive Officer

November 6, 2009
Exhibit 32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Albemarle Corporation (the “Company”) for the period ended September 30, 2009 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Richard J. Diemer, Jr., Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

  (1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

  (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ RICHARD J. DIEMER, JR.
Richard J. Diemer, Jr.
Senior Vice President and Chief Financial Officer
November 6, 2009